Manufacturer record

Addapt Life Care Pvt.Ltd: regulatory record

Last checked 3 November 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories

1 batch manufactured by Addapt Life Care Pvt.Ltd (Uttarakhand) was declared Not of Standard Quality in September 2026. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.

Most recent flagged batch: NT-2622, Nitrazepam Tablets IP 10 mg (exp Jan 2028). RDTL, Ernakulam (state lab) found it not of standard quality: The Sample does not conform to IP standards with respect to the test Dissolution. Listed in the September 2026 alert.

Records by type

1 record linked to Addapt Life Care Pvt.Ltd in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.

0Banned or prohibited
0Recalled or suspended
1Failed a lab test
0Regulatory notice
Primary government sourceTier 1: government primary source

CDSCO drug alerts: Not of Standard Quality and spurious drugs

CDSCO · CDSCO monthly NSQ alerts, Sep 2026 to Sep 2026

View original document

Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.

1
NSQ batches since 2026
1
Products affected
Dissolution
Most common failure
Sep 2026
Latest alert

Flagged batches per year

2026 · 1

All flagged batches

Product Batch Reason declared NSQ Tested by Alert
Nitrazepam Tablets IP 10 mg Batch NT-2622Mfg Feb 2026 · Exp Jan 2028 The Sample does not conform to IP standards with respect to the test Dissolution.Dissolution RDTL , ErnakulamState lab Sep 2026

Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.